Jonathan Thomas Charles Slade
Treasurer at ASTRAZENECA PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc Dunoyer | M | 71 |
Astrazeneca Intermediate Holdings Ltd.
 Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK. | 11 years |
| Ahmed Hamdy | M | 59 | 11 years | |
| Adrian Charles Noel Kemp | M | 58 |
Astrazeneca Treasury Ltd.
 Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The company is based in Cambridge, UK.
AstraZeneca US Investments Ltd.
 AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2002.
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK. | 15 years |
| Iain Alistair Collins | M | 54 |
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK.
Astrazeneca Sweden Investments Ltd.
 Astrazeneca Sweden Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Sweden Investments Ltd. is a science-led biopharmaceutical business. The company is based in Cambridge, UK. Astrazeneca's innovative medicines are used by millions of patients worldwide.
Astrazeneca Treasury Ltd.
Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The company is based in Cambridge, UK. | - |
| Jeffrey Pott | M | - | 29 years | |
| Michel Demaré | M | 67 | 5 years | |
| Aradhana Sarin | M | 50 | 3 years | |
| Nazneen Rahman | M | - | 7 years | |
| Shu Kam Mok | M | 63 | 5 years | |
| Deborah DiSanzo | F | 64 | 7 years | |
| Sherilyn McCoy | F | 65 | 7 years | |
| Philip Broadley | M | 63 | 7 years | |
| Marcus Wallenberg | M | 68 | 25 years | |
| Pam Cheng | F | 53 | 9 years | |
| Pascal Soriot | M | 64 | 12 years | |
| Josie Afolabi | F | - | 14 years | |
| Cindy Hoots | F | 56 | 4 years | |
| Regina Danielson | M | 60 | - | |
| Iskra Reic | F | - | 23 years | |
| Sjoerd Hubben | M | - | 8 years | |
| Alberto Hegewisch | M | - | 1 years | |
| Helen MacPhee | F | 64 | - | |
| Katie Louise Jackson-Turner | F | 58 |
AstraZeneca US Investments Ltd.
AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2002. | 9 years |
| Margareta Elisabeth Björk | M | 63 | 22 years | |
| David Fredrickson | M | - | 7 years | |
| Tyrell J. Rivers | M | 51 | 10 years | |
| Euan Ashley | M | - | 4 years | |
| Anna Olive Magdelene Manz | F | 51 | 1 years | |
| Susan Mary Galbraith | M | - | 14 years | |
| Ruud Dobber | M | - | 27 years | |
| Diana Layfield | F | - | 4 years | |
| Jan-Olof Jacke | M | 59 |
Astrazeneca Sweden Investments Ltd.
Astrazeneca Sweden Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Sweden Investments Ltd. is a science-led biopharmaceutical business. The company is based in Cambridge, UK. Astrazeneca's innovative medicines are used by millions of patients worldwide. | - |
| Andreas Rummelt | M | 67 | 3 years | |
| Kevin Lokay | M | 67 | 6 years | |
| Sharon Barr | F | - | 1 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Thomas Charles Slade
- Personal Network
